SCHEMBL21729327

SCHEMBL21729327

NC(Cc1ccc2c(c1)OCCO2)CN1CCCC1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 2/20 0.56
CYP2D6 P10635 1/20 0.47
TAAR1 Q96RJ0 2/20 0.47
SLC6A2 P23975 1/20 0.47
SLC6A3 Q01959 1/20 0.47
DPP7 Q9UHL4 1/20 0.46
KMT2A Q03164 1/20 0.45
ALKBH5 Q6P6C2 1/20 0.41
FTO Q9C0B1 1/20 0.41
ALDH1A1 P00352 1/20 0.41
MAPT P10636 1/20 0.41
HSD17B10 Q99714 1/20 0.41
PARP1 P09874 1/20 0.41
UGCG Q16739 5/20 0.40
OPRM1 P35372 2/20 0.40
HTR1A P08908 1/20 0.40
PTGS1 P23219 1/20 0.40
OPRD1 P41143 1/20 0.40
OPRK1 P41145 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2600416 1.00 SLC6A4 (0.56) SLC6A4CYP2D6TAAR1SLC6A2SLC6A3
SCHEMBL13460314 1.00 SLC6A4 (0.56) SLC6A4CYP2D6TAAR1SLC6A2SLC6A3
SCHEMBL21729367 0.99 SLC6A4 (0.55) SLC6A4CYP2D6TAAR1SLC6A2SLC6A3
SCHEMBL21309297 0.85 SLC6A4 (0.50) SLC6A4CYP2D6TAAR1SLC6A2SLC6A3
SCHEMBL19043185 0.83 CHRM3 (0.48) SLC6A4CYP2D6TAAR1SLC6A2SLC6A3
SCHEMBL7997916 0.83 CHRM3 (0.48) SLC6A4CYP2D6TAAR1SLC6A2SLC6A3
SCHEMBL24045408 0.82 SLC6A4 (0.49) SLC6A4CYP2D6TAAR1SLC6A2SLC6A3
SCHEMBL19043529 0.81 CYP2D6 (0.45) SLC6A4CYP2D6TAAR1SLC6A2SLC6A3
SCHEMBL19625066 0.80 CYP2D6 (0.48) SLC6A4CYP2D6TAAR1SLC6A2SLC6A3
SCHEMBL20799431 0.79 SLC6A4 (0.35) SLC6A4SLC6A3KMT2AALDH1A1UGCG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3611171-A1 METHOD FOR SYNTHESIS OF ELIGLUSTAT AND INTERMEDIATE COMPOUNDS THEREOF Zhejiang Ausun Pharmaceutical Co., Ltd. (CN) 2020-02-19 EP disclosed